Development and validation of pathology-based artificial intelligence diagnostic model for lymph node metastasis of prostate cancer

Status

Recruiting

Phases

Early Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR2200063872

Enrollment

Unknown

Registered

2022-09-19

Start date

2022-10-01

Completion date

Unknown

Last updated

2023-08-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

prostate cancer

Interventions

Gold Standard:Pathologic diagnosis

Index test:Artificial intelligence diagnosis

Eligibility

Sex/Gender

Male

Age

No minimum to 100 Years

Inclusion criteria

Inclusion criteria: 1. Patients with prostate cancer underwent radical prostatectomy + pelvic lymph node dissection; 2. Complete clinical and pathological data.

Exclusion criteria

Exclusion criteria: Complicated with other tumors.

Design outcomes

Primary

Measure	Time frame
accuracy;	—

Countries

China

Contacts

Public ContactLin Tianxin

Sun Yat-sen Memorial Hospital, Sun Yat-sen University

lintx@mail.sysu.edu.cn+86 13724008338

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026